Please provide your email address to receive an email when new articles are posted on . A new study will evaluate MFCL and atropine as a combination therapy for ...

Child eye test and eye exam. Little girl having eye check-up, with phoropter. Doctor performs eye test for child. This story is part of a series on the current progression in Regenerative Medicine.

A study conducted at Vanderbilt University Medical Center and 11 other hospitals and practices across the United States shows that use of low-dose atropine eyedrops, commonly used in a higher dose to ...

According to a secondary analysis of the 24- Month Myopia Outcome Study of Atropine in Children (MOSAIC) trial, 0.05% atropine eye drops were more effective in controlling myopia progression and axial ...

Please provide your email address to receive an email when new articles are posted on . Atropine eye drops had no effect on U.S. children’s myopia, unlike previous studies of Asian children.

Childhood myopia progression could be treated with low-dose atropine due to the safety and efficacy displayed in this study. The global prevalence of myopia was estimated to be 30% to 34% in 2020 and ...

Children with myopia using 0.05% atropine eye drops had less myopia progression and/or less axial elongation compared with those using placebo or 0.01% atropine, though they had higher rates of ...

Treating U.S. children with an investigational low-dose (0.01%) formulation of atropine eye drops didn't delay worsening of nearsightedness, a randomized clinical trial found. Over 24 months, kids ...